Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice
Open Access
- 28 February 2011
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 140 (2), 697-708.e4
- https://doi.org/10.1053/j.gastro.2010.08.020
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-αJCI Insight, 2009
- CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous toleranceLiver Transplantation, 2009
- Toll-like receptors as targets in chronic liver diseasesGut, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasomeJCI Insight, 2009
- The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88Hepatology, 2008
- TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniaeCellular Immunology, 2007
- A Bioartificial Liver Device Secreting Interleukin-1 Receptor Antagonist for the Treatment of Hepatic Failure in RatsJournal of Surgical Research, 2007
- AASLD position paper: The management of acute liver failureHepatology, 2005
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005